Kerbside

The recommendations provided in this column are taken from various market sources such as brokers, analysts, dealers and investment strategists, etc. These recommendations may not be backed by strong fundamentals. Therefore we advise readers to use their own discretion before investing in these recommendation 

FRESH HIGH 

Tata Power 

BSE Code: 500400
CMP: Rs 80.40 

The stock price of Tata Power has hit a fresh one-month high after the company welcomed the resolution by the Government of Gujarat to accept the recommendations of the High Power Committee in giving some relief to Mundra Ultra Mega Power Project that meets nearly 15 per cent of Gujarat’s requirement of power at a very reasonable cost. This relief will help the company’s wholly-owned subsidiary Coastal Gujarat Power Ltd (CGPL) to continue its operations to meet its obligations to all the five beneficiary states. Market gossip is that the stock is likely to continue its northward momentum and investors can take their bets on this scrip to make some quick bucks. 

RELAXED NORMS 

Capri Global Capital (CGCL) 

BSE Code: 531595
CMP: Rs 126 

The company operates in two major verticals – MSME loans and housing finance. Recently, the Reserve Bank of India (RBI) relaxed norms for NBFCs to securitise their loan books and, as per a source, this is a positive move for the NBFCs offering mortgage loans, especially to MSMEs, where over 90 per cent of their loan book is likely to become eligible for securitisation and this move will further spur liquidity in the system. Investors with some risk appetite may enter the stock with a strict stop loss. 

CONSOLIDATION 

UltraTech Cement 

BSE Code: 532538
CMP: Rs 3970 

UltraTech Cement is the largest manufacturer of grey cement, ready mix concrete (RMC) and white cement in India. It is also one of the leading cement producers globally. The stock has seen good consolidation over the last couple of weeks, and according to one of the leading technical analysts, the stock is poised for an upmove in the near term. High-risk traders can take exposure in this stock for handsome gains in the short term. 

AND FINALLY.. 

Jubilant Life Sciences 

BSE Code: 530019
CMP: Rs 819.05 

The company recently announced that its arm Drug Discovery and Development Solutions, Singapore, has entered into an agreement to acquire 10 per cent stake in Inipharm Inc USA. Also, one of the leading investment and fund management services has upgraded its rating. The company is witnessing improving trends across various key verticals and continues to guide for a better 2HFY19 vs 1HFY19. Investors with a medium term view can buy this stock.